Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1998;32:25-32

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ghiadoni, L.
Right arrow Articles by Salvetti, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ghiadoni, L.
Right arrow Articles by Salvetti, A.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*High Blood Pressure

(Hypertension. 1998;32:25-32.)
© 1998 American Heart Association, Inc.


Scientific Contributions

Endothelial Function and Common Carotid Artery Wall Thickening in Patients With Essential Hypertension

Lorenzo Ghiadoni; Stefano Taddei; Agostino Virdis; Isabella Sudano; Virgilio Di Legge; Mario Meola; Lorenzo Di Venanzio; ; Antonio Salvetti

From the I Clinica Medica, University of Pisa, Italy.

Correspondence to Dr Stefano Taddei, I Clinica Medica, University of Pisa, Via Roma 67, 56100 Pisa, Italy. E-mail s.taddei{at}int.med.unipi.it


*    Abstract
up arrowTop
*Abstract
down arrowIntroduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Abstract—Intimal-medial thickening of the carotid wall is considered an early marker of atherosclerosis. Endothelial function is impaired in the presence of various cardiovascular risk factors that are implicated in the pathogenesis of atherosclerosis. To evaluate the relationship between vascular reactivity and carotid intimal-medial thickening, in 44 (mean±SD age, 45.7±8.8 years; range, 28 to 60 years; 31 men and 13 women) patients with essential hypertension who had never been treated and whose history of increased blood pressure was no longer than 12 months, we evaluated several parameters: intimal-medial thickening of the common carotid arteries (by B-mode ultrasound); forearm vascular response (by strain-gauge plethysmography) to intrabrachial infusion of acetylcholine (0.15, 0.45, 1.5, 4.5, and 15 µg/100 mL forearm tissue per minute), an endothelium-dependent vasodilator, or sodium nitroprusside (1, 2, and 4 µg/100 mL forearm tissue per minute), an endothelium-independent vasodilator; calculated minimal forearm vascular resistances (the ratio between mean arterial pressure and maximal forearm vasodilation induced by 13 minutes of ischemia and 1 minute of exercise); and left ventricular mass index (on echocardiography profile). Carotid wall intimal-medial thickening showed a significant (P<0.001) inverse correlation with vasodilation to acetylcholine (r=-0.58) and age (r=-0.40), whereas no correlation was observed with the response to sodium nitroprusside or with minimal forearm vascular resistances, left ventricular mass index, systolic and diastolic blood pressures, and plasma cholesterol and glucose levels. Moreover, vasodilation to acetylcholine showed no correlation with minimal forearm vascular resistances or left ventricular mass index. Although comparison of different vascular "districts," such as the forearm microcirculation and carotid artery, does not allow for a conclusive interpretation, the present data indicate that in patients with essential hypertension, carotid wall thickening is associated with reduced endothelium-dependent vasodilation and suggest that endothelial dysfunction might be involved in early arterial structural alterations.


Key Words: endothelium • carotid arteries • hypertension, essential • acetylcholine • sodium nitroprusside


*    Introduction
up arrowTop
up arrowAbstract
*Introduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Although essential hypertension is defined as a genetic disease characterized by consistently elevated BP values, its clinical relevance arises from the associated increased predisposition to cardiovascular morbidity and mortality.1 Probably the most important mechanism by which essential hypertension acts as a cardiovascular risk factor is the induction of atherosclerosis.1 However, the pathological events leading from high BP to atherosclerotic lesions are still to be fully clarified.

It is well documented that functional or morphological alterations of endothelial cells appear to be critical to the evolution, progression, and clinical manifestation of atherosclerotic vascular disease.2 3 In addition, endothelial dysfunction has been documented in the presence of atherosclerotic lesions,4 and it predicts the development of atherosclerotic lesions in epicardial vessels of cardiac transplant patients.5 Moreover, endothelial dysfunction has also been documented in the presence of different cardiovascular risk factors involved in the pathogenesis of atherosclerosis itself, such as hypertension,6 7 8 9 aging,9 10 menopause,10 hypercholesterolemia,11 12 diabetes mellitus,13 14 and smoking.15

In recent years, ultrasound imaging of the extracranial carotid arteries has been extensively used to detect early arterial wall abnormalities. Moreover, IMT of the carotid wall has been considered an early marker of atherosclerosis16 and a possible index of coronary artery atherosclerosis.17

The aim of the present study was to evaluate the relation between carotid wall IMT with different functional and structural cardiovascular parameters and humoral factors in patients with essential hypertension. Moreover, to better clarify the link between essential hypertension and induction of atherosclerosis, we avoided confounding factors, such as previous pharmacological antihypertensive treatment or the frequently encountered impossibility of ascertaining the duration of hypertensive disease. Therefore, in the present study, we selected only those patients who had never been treated and who had a documented history of essential hypertension no longer than 12 months.


*    Methods
up arrowTop
up arrowAbstract
up arrowIntroduction
*Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Patients
The study population included 30 normotensive subjects (20 men and 10 women) and 44 patients with essential hypertension (31 men and 13 women). Subjects with marked hypercholesterolemia (total cholesterol >6.2 mmol/L), a heavy smoking habit (>10 cigarettes/d), diabetes mellitus, cardiac or cerebral ischemic vascular disease, impaired renal function, and other major pathologies were excluded from the study. In accordance with institutional guidelines, the protocol was approved by the ethics committee of the University of Pisa. All patients were aware of the investigational nature of the study and gave their written consent.

Essential hypertension patients were recruited with the collaboration of 10 general practitioners working in the city of Pisa. The practitioners were asked to enroll patients with recent-onset essential hypertension (no more than 12 months). It is worth noting that patients were enrolled only if they reported a history of periodic BP measurements. This criterion excluded the possibility of detecting hypertension that corresponded to the first BP measurement in a patient's life, which would have led to difficulty in ascertaining the time of onset of hypertensive disease. In all cases, subjects were characterized by the presence of a positive family history of essential hypertension and a supine arterial BP (after 10 minutes of rest) consistently >140/90 mm Hg, as measured by mercury sphygmomanometer three times at 1-week intervals. Secondary forms of hypertension were excluded as follows: renovascular disease was excluded in most cases by renal artery color Doppler echography, whereas in 16 of 44 patients, renal angiography was performed; renal parenchymal diseases was ruled out by the normality of serum creatinine levels, urine examination, and renal echotomography; primary aldosteronism was ruled out by the absence of hypokalemia and the normality of plasma renin activity and aldosterone; pheochromocytoma was ruled out by the normality of plasma catecholamine levels and the absence of an adrenal or abdominal mass on echotomography. Mean age was 45.7±8.8 years (range, 28 to 60 years). BP values were 158.8±13.2/101.7±6.9 mm Hg. As control subjects, 30 healthy normotensive volunteers (mean±SD age, 44.7±6.6 years; mean±SD BP, 116.8±3.6/75.4±4.1 mm Hg) were enrolled.

Drugs
Ach HCl (Farmigea SpA) and SNP (Malesci) were obtained from commercially available sources and freshly diluted to the desired concentration by adding normal saline. SNP was dissolved in glucosate solution and protected from light with aluminum foil.

Experimental Procedures
Each subject underwent the following examinations: B-mode ultrasound imaging of the carotid artery, echocardiographic examination, and FBF studies.

Carotid Artery B-Mode Ultrasound Imaging
High-resolution B-mode ultrasound examination of the carotid arteries was performed with a Biosound 2000 IISA with a 7.5-MHz transducer. Sonography and readings were carried out by trained and certified sonographers with regular quality-control checks (Division of Vascular Ultrasound Research, Bowman Gray School of Medicine of Wake Forest University), as previously described by Crouse et al.18 Patients were examined in the supine position, and each carotid wall and segment was examined independently from continuous angles to identify the thickest intimal-medial site. Each scan of the common carotid artery began just above the clavicle, and the transducer was moved cephalad past the bifurcation and along the internal carotid artery. Three segments were identified on each side: the distal 1.0 cm of the common carotid proximal to the bifurcation, the bifurcation itself, and the proximal 1.0 cm of the internal carotid artery. At each of the three segments for both near and far walls in the left and right carotid arteries, the sonographer identified two interfaces: on the near wall, the first interface (interface 2) was the adventitial-medial boundary, and the second (interface 3), the intimal-luminal boundary; on the far wall, the first interface (interface 4) was the luminal-intimal boundary, and the second (interface 5), the medial-adventitial boundary. Thus, the distances between interfaces 2 and 3 and between 4 and 5 define the IMTs on the near and far walls, respectively. When these interfaces had been imaged distinctly, the sonographer reduced the gain and time-gain control settings to as low as possible to decrease artifacts; the video images that included the maximum near- and far-wall IMTs at each of the 12 segments were then recorded. Images were transcribed onto SVHS 1/2-in. videotape. Frames that identified the maximum near- and far-wall IMTs within each segment were interfaced to a high-resolution monitor, and maximum wall diastolic (minimal carotid diameter) thickness was calculated at each site. Under our experimental conditions, the variability of measurements was 7.9±0.3%. For this study, the mean of the aggregate of all 12 sites and the maximum of all 12 sites were calculated. Because of the highly significant correlation between these two parameters (r=0.83, P<0.0001), the analysis was performed with only the maximum thickness of all 12 sites.

Patients with an IMT <1 mm were considered normal, patients with an IMT between 1 and 1.3 mm were considered to have wall thickening, and patients with an IMT >1.3 mm were considered to have plaque.18 19 The operator (L.D.V.) was blinded with respect to the results of other evaluations.

Echocardiographic Evaluation
Echocardiograms (SIM 500, Esaote Biomedica) were performed from parasternal and apical windows with the subjects in the left lateral decubitus position. An ECG tracing with an easily discernible QRS complex was chosen. The dimensions of the left ventricle, septum, and posterior wall were obtained at the beginning of the QRS complex, with the ultrasound beam passing through the left ventricle at the level of the tips of the mitral valve leaflets. Following the recommendations of the Penn Convention, we measured (in centimeters) the diastolic thickness of the left interventricular septum and left ventricular posterior wall, as well as the diastolic dimension of the left ventricular chamber; these measurements were inserted into the mathematical model for the prediction of LVMI according to Devereux et al.20 The operator (V.D.L.) was blinded with respect to the results of other evaluations.

FBF Studies
All studies were performed at 8 AM after an overnight fast, with the subjects lying supine in a quiet, air-conditioned room (22°C to 24°C). A polyethylene cannula (21 gauge, Abbot) was inserted into the brachial artery under local anesthesia (2% lidocaine) and connected through stopcocks to a pressure transducer (model MS20, Electromedics) for systemic mean BP (1/3 pulse pressure+diastolic pressure) and heart rate (model VSM1, Physiocontrol) monitoring and for intra-arterial infusions. FBF was measured in both forearms (experimental and contralateral forearm) by strain-gauge venous plethysmography (LOOSCO, GL LOOS).21 Circulation to the hand was excluded 1 minute before FBF measurement by inflating a pediatric cuff around the wrist at suprasystolic blood pressure. Details concerning the sensitivity and reproducibility of the method as performed in our laboratory have already been published.22

Forearm volume was measured according to the water-displacement method, and drug infusion rates were normalized for 1 dL of tissue by adjusting the concentration of the stock solution to the desired infusion rate. Drugs were infused at systemically ineffective rates through separate ports via three-way stopcocks. The operator (A.V.) was blinded with respect to the results of other evaluations.

Endothelium-dependent vasodilation was estimated by performing a dose-response curve to intra-arterial Ach (cumulative increase of the infusion rates were 0.15, 0.45, 1.5, 4.5, and 15 µg per 100 mL of forearm tissue per minute for 5 minutes at each dose). Endothelium-independent vasodilation was assessed with a dose-response curve to intra-arterial SNP, a direct smooth muscle cell relaxant compound,23 (cumulative increase by 1, 2, and 4 µg per 100 mL of forearm tissue per minute for 5 minutes at each dose). These rates were selected to induce vasodilation comparable to that obtained with Ach.

MFVRs were calculated as the ratio between maximal postischemic FBF increase (after 13 minutes of ischemia plus 1 minute of dynamic hand exercise) and intra-arterial mean arterial pressure, as previously described.24 The sequence of the experimental interventions was randomized, and a 45-minute recovery period was allowed between the three experimental steps.

Data Analysis
Results are expressed as mean±SD. Differences between means in Table 1Down were analyzed by Student's t test for unpaired data. FBF data were analyzed as absolute values by ANOVA for repeated measures; Scheffé's test was applied for multiple comparison testing. Differences were considered statistically significant at P<0.05.


View this table:
[in this window]
[in a new window]
 
Table 1. Characteristics of Study Subjects

Interactions between carotid wall thickening and forearm vasodilation to Ach, SNP (considered as the maximum effect), age, BP, LVMI, MFVR, plasma total cholesterol, and plasma HDL and LDL cholesterol were calculated by both simple correlation and multiple regression analyses.


*    Results
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
*Results
down arrowDiscussion
down arrowReferences
 
The baseline systemic demographic, hemodynamic, and humoral characteristics for normotensive subjects and essential hypertension patients are summarized in Table 1Up. No difference was found between the two groups, with the exclusion of BP values. The mean carotid maximal IMT was 1.0±0.1 mm in normotensive subjects and 1.2±0.3 in essential hypertension patients (P<0.01 versus normotensives). According to the results of the carotid scanning, hypertensive patients were divided into three groups: (1) n=13 patients were found to be normal (ie, an IMT of 0.9±0.1 mm); (2) n=20 patients had IMT thickening (IMT of 1.2±0.1 mm); and (3) n=11 patients had plaque (IMT of 1.6±0.2 mm). These subgroups of hypertensive subjects presented no differences in the hemodynamic and humoral characteristics considered (Table 2Down).


View this table:
[in this window]
[in a new window]
 
Table 2. Demographic, Hemodynamic, and Humoral Characteristics of Essential Hypertension Patients (n=44) Divided Into Three Subgroups According to Carotid Wall Thickening

Ach caused dose-dependent vasodilation, which was shown to be significantly blunted in essential hypertension patients compared with normotensive subjects (FBF rose from 3.4±0.5 to 24.8±4.8 and 3.5±0.4 to 35.1±7.1 mL per 100 mL of forearm tissue per minute, respectively; P<0.001) (Figure 1Down). In contrast, the response to SNP was similar in controls and hypertensive patients (FBF rose from 3.6±0.4 to 27.9±3.6 and 3.4±0.6 to 26.5±4.3 mL per 100 mL of forearm tissue per minute, respectively) (Figure 1Down). When the response to Ach was also examined in the three subgroups of hypertensive patients, it was found that endothelium-dependent vasodilation was significantly lower in essential hypertension patients with thickening (FBF rose from 3.4±0.5 to a maximum of 21.9±3.1 mL per 100 mL of forearm tissue per minute) and plaque (FBF rose from 3.4±0.7 to a maximum of 17.9±3.7 mL per 100 mL of forearm tissue per minute) than in hypertensive patients with a normal IMT (FBF rose from 3.2±0.6 to a maximum of 29.6±5.2 mL per 100 mL of forearm tissue per minute; P<0.05) (Figure 2Down). However, in the normal IMT subgroup, the vasodilating effect of Ach was still lower than that in normotensive subjects (P<0.05). The response to SNP was still similar in the three hypertensive subgroups (for normal IMT, FBF rose from 3.4±0.5 to a maximum of 27.8±4.3; for those with thickening, FBF rose from 3.5±0.4 to a maximum of 26.4±3.6; and for those with plaque, FBF rose from 3.6±0.6 to a maximum of 24.2±3.5 mL per 100 mL of forearm tissue per minute) (Figure 2Down). In normotensive subjects, no significant correlation was found between carotid IMT and the response to Ach or SNP (r=-0.10, P=NS and r=-0.08, P=NS, respectively).



View larger version (15K):
[in this window]
[in a new window]
 
Figure 1. FBF increase above basal levels (b) induced by intra-arterial Ach (µg per 100 mL of forearm tissue per minute) (left) and SNP (SNP, µg per 100 mL of forearm tissue per minute) (right) in 44 essential hypertension patients ({circ}) and 30 normotensive subjects ({bullet}). Data are shown as mean±SD. and reported as absolute values. Asterisks denote significant difference between hypertensive patients and normotensive subjects (*P<0.001).



View larger version (16K):
[in this window]
[in a new window]
 
Figure 2. FBF increase above basal levels (b) induced by intra-arterial Ach (µg per 100 mL of forearm tissue per minute) (left) and SNP (µg per 100 mL of forearm tissue per minute) (right) in 44 essential hypertension patients divided into three subgroups: patients with <1 mm IMT ({bullet}), those with IMT of 1 to 1.3 mm ({circ}), and those with IMT >1.3 mm ({square}). Data are shown as mean±SD and reported as absolute values. Asterisks denote a significant difference between the three subgroups of hypertensive patients (*P<0.05 or less).

In essential hypertension patients, a significant inverse correlation was found between carotid artery IMT and Ach-induced forearm vasodilation, as evaluated in terms of FBF response to the highest infusion rate of the agonist (15 µg per 100 mL of forearm tissue per minute; r=-0.58, P=0.0003) (Figure 3Down), whereas no correlation was observed with the response to SNP (FBF response to the highest infusion rate (4 µg per 100 mL of forearm tissue per minute, r=-0.06, P=NS). Age was positively and significantly correlated with carotid artery IMT (r=0.40, P=0.022) (Figure 3Down) and inversely and significantly with the maximal response to Ach (r=-0.51, P=0.001).



View larger version (17K):
[in this window]
[in a new window]
 
Figure 3. Relationship between carotid wall thickening (x axis) and age (y axis, top) and FBF response to the highest infusion rate of Ach (15 µg per 100 mL of forearm tissue per minute) (y axis, bottom) in 44 essential hypertension patients.

In addition, no correlation was observed between carotid artery IMT and systolic (r=-0.05, P=NS) or diastolic (r=-0.2, P=NS) BP. However, when the data from essential hypertension patients were considered together with data from normotensive subjects, a positive correlation was observed between IMT and systolic (r=0.39, P<0.001) and diastolic (r=0.34, P<0.01) BP. Finally, no correlation was observed between carotid IMT and MFVR (r=-0.2, P=NS), LVMI (r=0.09, P=NS), total cholesterol (r=-0.08, P=NS), HDL cholesterol (r=0.003, P=NS), LDL cholesterol (r=-0.04, P=NS), or plasma glucose (r=-0.13, P=NS).

Finally, multivariate regression analysis showed that the correlation between carotid IMT and the other parameters (r2=0.51) was influenced most by the maximal response to Ach (r2=0.35) and age (r2=0.15). When the effect of aging was taken into account in the analysis, the relationship between the response to Ach and carotid IMT remained statistically significant (from P<0.004 to P<0.03).


*    Discussion
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
*Discussion
down arrowReferences
 
At the present time, B-mode ultrasonography is extensively used to detect early structural changes in carotid arteries because the thickening process in these areas is considered a prognostic marker for the development of atherosclerosis16 and appears to correlate with coronary lesions.17 In the present study, we tested the possible existence of a relationship between early structural changes in carotid arteries and endothelial dysfunction in essential hypertension patients. Given the possibility that regression or induction of cardiovascular alterations, whether structural or functional, could be caused by long-term pharmacological treatment or different duration of hypertension,25 26 27 28 the present study was designed to recruit never-treated essential hypertension patients with a sufficiently accurate determination of disease onset. To pursue this aim, we cooperated with general practitioners who were asked to recruit subjects known to be undergoing measurement of BP values at least once every 6 months. Only subjects whose documented report of high BP values was no longer than 1 year were then enrolled.

Following these inclusion criteria, we selected a fairly homogeneous study population represented by never-treated essential hypertension patients with a short duration of the disease. Moreover, apart from high BP, the hypertensive patients studied were characterized by normal glucose and lipid profiles and a moderate prevalence of smoking history. In line with previous evidence,5 6 7 8 9 these patients showed endothelial dysfunction because vasodilation to Ach but not to SNP was found to be reduced compared with that of normotensive control subjects. However, the interesting finding of the present study is that when essential hypertension patients were divided into three subgroups according to the different carotid IMT findings, the response to Ach, while still impaired in patients with a normal IMT compared with normotensive patients, showed a further significant reduction in patients with thickening of the carotid artery and an even greater reduction in patients with plaque. Because the vasodilating effect of SNP proved to be similar in the three subgroups of hypertensive patients, the present results indicate that IMT of the extracranial carotid arterial wall is associated with blunted endothelium-dependent vasodilation in essential hypertension. This hypothesis is reinforced by the finding that in this study population of essential hypertension patients, carotid IMT showed a negative and significant correlation with maximal response to Ach but not to SNP. In contrast, carotid IMT of the control subjects showed no correlation with vasodilation to Ach.

Finally, in essential hypertension patients, the response to Ach was not correlated with the calculated MFVR or LVMI, which are indexes of arteriolar29 and cardiac28 structural alterations, respectively. Moreover, no correlation was found between IMT of the carotid arteries and LVMI or MFVR.

These results suggest that in our study population of never-treated essential hypertension patients with a relatively low cardiovascular risk, there is a possible link between endothelial dysfunction and early structural changes of a large conduit artery, such as the carotid. On the other hand, the lack of correlation between endothelial dysfunction and MFVR or LVMI suggests that such alterations could be determined by different mechanisms. This possibility is in agreement with the evidence that blunted endothelium-dependent vasodilation is a "primitive" phenomenon and not secondary to the development of hypertension because this response is present in the normotensive offspring of essential hypertension patients,30 shows no significant correlation with BP values,9 31 and is not reversed by BP normalization.32 33 In contrast, cardiac and microvascular structural alterations seem to be more closely related to BP values.26 28

The lack of correlation between carotid IMT and LVMI is at variance with previous reports.34 35 However, the discrepancy can be explained by the fact that in the article by Roman et al,34 the study population included both normotensive and hypertensive patients in the analysis, with a wide range of LVMI values. Moreover, the study of Cuspidi et al35 also considered patients with concentric remodeling.

Taken together, the present findings suggest that a dysfunctional endothelium can be a predisposing factor to the development of atherosclerosis. If this is the case, it is worth noting that the subgroup of essential hypertension patients with a normal carotid IMT was characterized by a response to Ach that was significantly lower than that observed in normotensive controls. It is therefore conceivable that a certain degree of endothelial dysfunction is necessary to observe a detectable association with atherosclerosis. However, another possible explanation for the latter result could lie in the major limitation of the present study, namely, the comparison of two different vascular districts, the forearm and carotid vasculature, with different structures (microcirculation and large arteries, respectively). The forearm vasculature is not usually affected by atherosclerosis; in addition, vascular reactivity in the microcirculation is sometimes different from that observed in large arteries.36 It is therefore crucial to avoid conclusive statements, and further studies are needed to provide more detailed confirmation of the association between endothelial dysfunction and early development of atherosclerosis in the carotid arteries.

The mechanism through which a dysfunctioning endothelium could promote atherosclerosis is related to the evidence that endothelial dysfunction is caused by an alteration in the L-arginine–NO pathway,37 leading to a reduction of NO bioavailability.38 NO appears to be not only a potent vasodilator but also an endogenous inhibitor of platelet aggregation,39 vascular smooth muscle cell growth and migration,40 41 leukocyte adhesion,42 and adhesion molecule expression.43 It is clear that an alteration in the L-arginine–NO pathway may reduce this potentially antiatherosclerotic activity. In addition, a dysfunctional endothelium can also produce prostanoids such as thromboxane A2, which causes vasoconstriction and platelet aggregation,44 and/or oxygen free radicals, which can destroy NO45 and cause vascular damage.46 Of relevance is the finding that in the aorta and carotid artery of spontaneously hypertensive rats, endothelial dysfunction is associated with monocyte/macrophage infiltration,47 suggesting that endothelial activation could constitute an early event in hypertension, leading to both increased monocyte adherence and chemotaxis and abnormal production of endothelium-derived constricting factors. Alternatively, the monocytes/macrophages might themselves secrete constricting factors or further activate endothelial cells. In conclusion, it may be suggested that in essential hypertension, the mechanisms causing endothelial dysfunction can potentially lead to atherosclerosis. This hypothesis seems to be confirmed by the finding that an impairment in the NO system is not an exclusive characteristic of essential hypertension.37 38 It has also been demonstrated in the presence of the majority of cardiovascular risk factors, such as aging,48 hypercholesterolemia,12 diabetes,13 and smoking,15 all pathological conditions characterized by an increased predisposition to the development of atherosclerosis. As a final speculation, it is possible that the increased wall thickness may impair diffusion of endothelial vasoactive substances to smooth muscle cells, thereby impairing endothelium-dependent vasodilation. However, this hypothesis seems to be indirectly excluded by the results with SNP. This compound acts directly on smooth muscle as NO source cells, and no different effect was observed in normotensive subjects or essential hypertension patients with normal IMT compared with hypertensive patients with plaque.

Another major factor to be considered is the role of aging. The present study confirms previous evidence indicating a positive correlation between IMT of the carotid artery and aging.34 36 There is also a well-documented association between advancing age and impaired endothelium-dependent vasodilation.9 10 11 Thus, aging itself could be the main phenomenon involved, leading in a parallel manner to both the development of carotid structural alterations and impaired endothelium-dependent vasodilation. An alternative possibility is that the summation of the simultaneous negative effects of aging and hypertension could result in more pronounced impairment of endothelial function, thereby leading to atherosclerosis. The consideration that our study population was represented by essential hypertension patients with very low cardiovascular risk points to the possibility that aging could play a key role in explaining the association between carotid artery structural alterations and endothelial dysfunction. However, even after accounting for the role of aging, the inverse relationship between the response to Ach and IMT remained statistically significant.

Finally, in these essential hypertension patients, we found no correlation between carotid IMT and other important atherosclerosis risk factors, such as high BP and unfavorable glucose and lipid profiles, a result that is at variance with several previous observations.36 49 50 A likely explanation could be the fact that, in accordance with the enrollment criteria, the present study population was characterized by the presence of high BP values as the only major cardiovascular risk factor. Thus, glucose and lipid profiles not only were within the normal range but also had a minimum range of variation. Therefore, these experimental conditions are probably inadequate to detect an association between these risk factors and carotid IMT. This possibility is reinforced by the evidence that analysis of the relationship between BP values and IMT in the entire study population (normotensives plus hypertensives, characterized by a larger range of BP values) showed a positive correlation between the parameters considered.

In conclusion, the present study indicates an association between carotid artery IMT and impaired endothelium-dependent vasodilation. Whether these vascular alterations are casually associated or indicate a causal relationship between endothelial dysfunction and development of atherosclerosis in essential hypertension remains to be established.


*    Selected Abbreviations and Acronyms
 
Ach = acetylcholine
BP = blood pressure
FBF = forearm blood flow
IMT = intimal-medial thickening
LVMI = left ventricular mass index
MFVR = minimal forearm vascular resistance
SNP = sodium nitroprusside

Received January 19, 1998; first decision February 2, 1998; accepted February 11, 1998.


*    References
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
up arrowDiscussion
*References
 
1. Wilson PWF, Kannel WB. Hypertension, other risk factors and the risk of cardiovascular disease. In: Laragh JH, Brenner BM, eds. Hypertension: Pathophysiology, Diagnosis and Treatment. New York, NY: Raven Press Publishers; 1995:99–114.

2. Ross R. The pathogenesis of atherosclerosis: an update. N Engl J Med. 1986;314:488–500.[Medline] [Order article via Infotrieve]

3. Chobanian A. Pathophysiology of atherosclerosis. Am J Cardiol. 1992;70:3G–7G.[Medline] [Order article via Infotrieve]

4. Yasue H, Matsuyama K, Matsuyama K, Okamura K, Morikami Y, Ogawa H. Response of angiographically normal human coronary arteries to intracoronary injection of acetylcholine by age and segment: possible role of early coronary atherosclerosis. Circulation. 1990;81:482–490.[Abstract/Free Full Text]

5. Davis SF, Yeung AC, Meredith IT, Charbonneau F, Ganz P, Selwyn P, Anderson TJ. Early endothelial dysfunction predicts the development of transplant coronary artery disease at 1 year post transplant. Circulation. 1996;93:457–462.[Abstract/Free Full Text]

6. Linder L, Kiowski W, Buhler FR, Luscher TF. Indirect evidence for the release of endothelium-derived relaxing factor in the human forearm circulation in vivo: blunted response in essential hypertension. Circulation. 1990;81:1762–1767.[Abstract/Free Full Text]

7. Panza JA, Quyyumi AA, Brush JE Jr, Epstein SE. Abnormal endothelium dependent vascular relaxation in patients with essential hypertension. N Engl J Med. 1990;323:22–27.[Abstract]

8. Taddei S, Virdis A, Mattei P, Salvetti A. Vasodilation to acetylcholine in primary and secondary forms of human hypertension. Hypertension. 1993;21:929–933.[Abstract/Free Full Text]

9. Taddei S, Virdis A, Mattei P, Ghiadoni L, Gennari A, Basile Fasolo C, Sudano I, Salvetti A. Aging and endothelial function in normotensive subjects and essential hypertensive patients. Circulation. 1995;91:1981–1987.[Abstract/Free Full Text]

10. Taddei S, Virdis A, Ghiadoni L, Mattei P, Sudano I, Bernini G, Pinto S, Salvetti A. Menopause is associated with endothelial dysfunction in women. Hypertension. 1996;28:576–582.[Abstract/Free Full Text]

11. Creager MA, Cooke JP, Mendelsohn ME, Gallagher SJ, Coleman SM, Loscalzo J, Dzau VJ. Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans. J Clin Invest. 1990;86:228–234.

12. Casino PR, Kilcoyne CM, Quyyumi AA, Hoeg JM, Panza JA. The role of nitric-oxide in endothelium-dependent vasodilation of hypercholesterolemic patients. Circulation. 1993;88:2541–2547.[Abstract/Free Full Text]

13. Williams SB, Cusco JA, Roddy M-A, Johnstone MT, Creager MA. Impaired nitric oxide mediated vasodilation in patients with non insulin-dependent diabetes mellitus. J Am Coll Cardiol. 1996;27:567–574.[Abstract]

14. Ting HH, Timini FK, Boles KS, Creager SJ, Ganz P, Creager MA. Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus. J Clin Invest. 1996;97:22–28.[Medline] [Order article via Infotrieve]

15. Heitzer T, Ylä-Herttuala S, Luoma J, Kurz S, Munzel T, Just H, Olschewski M, Drexler H. Cigarette smoking potentiates endothelial dysfunction of forearm resistance vessels in patients with hypercholesterolemia: role of oxidized LDL. Circulation. 1996;93:1346–1353.[Abstract/Free Full Text]

16. Poli A, Tremoli E, Colombo A. Ultrasonographic measurement of the common carotid artery wall thickness in hypercholesterolemic patients: a new model for the quantification and follow up of preclinical atherosclerosis in living human subjects. Atherosclerosis. 1988;70:253–261.[Medline] [Order article via Infotrieve]

17. Salonen JT, Salonen R. Ultrasonographically assessed carotid morphology and the risk of coronary heart disease. Arterioscler Thromb. 1991;11:1245–1249.[Abstract/Free Full Text]

18. Crouse JR III, Craven TE, Hagaman AP, Bond G. Association of coronary disease with segment specific intimal-medial thickening of the extracranial carotid artery. Circulation. 1995;92:1141–1147.[Abstract/Free Full Text]

19. Borhani NO, Mercuri M, Borhani PA, Buckalew VM, Canossa-Terris M, Carr AA, Kappadoga T, Rocco MV, Schnaper HW, Sowers JR, Bond G. Final outcome results of the multicenter isradipine diuretic atherosclerosis study (MIDAS). JAMA. 1996;276:785–791.[Abstract/Free Full Text]

20. Devereux RB, Alonso DR, Lertas EM, Gottlib GJ, Campo E, Sachs I, Reichek N. Echocardiographic assessment of left ventricular mass: comparison to necropsy findings. Am J Cardiol. 1986;57:450–458.[Medline] [Order article via Infotrieve]

21. Whitney RJ. The measurement of volume changes in human limbs. J Physiol (Lond). 1953;121:1–27.

22. Pedrinelli R, Taddei S, Graziadei L, Salvetti A. Vascular responses to ouabain and norepinephrine in low and normal renin hypertension. Hypertension. 1986;8:786–792.[Abstract/Free Full Text]

23. Schultz KD, Schultz K, Schultz G. Sodium nitroprusside and other smooth muscle relaxants increase cyclic GMP levels in rat ductus deferens. Nature. 1977;265:750–751.[Medline] [Order article via Infotrieve]

24. Pedrinelli R, Taddei S, Spessot M, Salvetti A. Maximal postischemic forearm vasodilation in human hypertension: a reassessment of the method. J Hypertens. 1987;5(suppl 5):S431–S433.

25. Agabiti-Rosei E, Rizzoni D, Castellano M, Porteri E, Zulli R, Muiesan ML, Bettoni G, Salvetti M, Muiesan P, Giulini SM. Media:lumen ratio in human small resistance arteries is related to forearm minimal vascular resistance. J Hypertens. 1995;13:341–347.[Medline] [Order article via Infotrieve]

26. Schiffrin LE, Deng LY. Structure and function of resistance arteries of hypertensive patients treated with a ß-blocker or a calcium channel antagonist. J Hypertens. 1996;14:1247–1255.[Medline] [Order article via Infotrieve]

27. Folkow B. The structural factor in hypertension with special emphasis on the altered geometric design of the systemic arteries. In: Laragh JH, Brenner BM, eds. Hypertension: Pathophysiology, Diagnosis and Treatment. New York, NY: Raven Press Publishers; 1995:481–502.

28. Devereux RB, Pickering TG, Harshfield GA, Kleinert HD, Denby L, Clark L, Pregibon B, Jason M, Kleiner B, Borer JS, Laragh JH. Left ventricular hypertrophy in patients with hypertension: importance of blood pressure response to regularly recurring stress. Circulation. 1983;68:1550–1558.

29. Rizzoni D, Muiesan ML, Porteri E, Castellano M, Zulli R, Bettoni G, Salvetti M, Monteduro C, Agabiti-Rosei E. Effects of long-term antihypertensive treatment with lisinopril on resistance arteries in hypertensive patients with left ventricular hypertrophy. J Hypertens. 1997;15:197–204.[Medline] [Order article via Infotrieve]

30. Taddei S, Virdis A, Mattei P, Ghiadoni L, Sudano I, Salvetti A. Defective L-arginine-nitric oxide pathway in offspring of essential hypertensive patients. Circulation. 1996;94:1298–1303.[Abstract/Free Full Text]

31. Panza JA, Quyyumi AA, Callahan TS, Epstein SE. Effect of antihypertensive treatment on endothelium-dependent vascular relaxation in patients with essential hypertension. J Am Coll Cardiol. 1993;21:1145–1151.[Abstract]

32. Creager MA, Roddy MA. Effect of captopril and enalapril on endothelial function in hypertensive patients. Hypertension. 1994;24:499–505.[Abstract/Free Full Text]

33. Kiowski W, Linder L, Nuesch R, Martina B. Effect of cilazapril on vascular structure and function in essential hypertension. Hypertension. 1996;27(pt 1):371–376.

34. Roman MJ, Saba PS, Pini R, Spitzer M, Pickering TG, Rosen S, Alderman MH, Devereux RB. Parallel cardiac and vascular adaptation in hypertension. Circulation. 1992;86:1909–1918.[Abstract/Free Full Text]

35. Cuspidi C, Lonati L, Sampieri L, Pellizzoli S, Pontiggia G, Leonetti G, Zanchetti A. Left ventricular concentric remodeling and carotid structural changes in essential hypertension. J Hypertens. 1996;14:1441–1446.[Medline] [Order article via Infotrieve]

36. Gariepy J, Simon A, Massonneau M, Linhart A, Segond P, Levenson J, Groupe PCVMETRA. Echographic assessment of carotid and femoral arterial structure in man with essential hypertension. Am J Hypertens. 1996;9:126–136.[Medline] [Order article via Infotrieve]

37. Panza JA, Casino PR, Kilcoyne CM, Quyyumi AA. Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension. Circulation. 1993;87:1468–1474.[Abstract/Free Full Text]

38. Taddei S, Virdis A, Ghiadoni L, Magagna A, Salvetti A. Cyclooxygenase inhibition restores nitric oxide activity in essential hypertension. Hypertension. 1997;29(pt 2):274–279.

39. Radomski MW, Palmer RMJ, Moncada S. Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet. 1987;2:1057–1068.[Medline] [Order article via Infotrieve]

40. Garg UC, Hassid A. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest. 1989;83:1774–1777.

41. Dubey RK, Ganten D, Lüscher TF. Enhanced migration of smooth muscle cells from Ren-2 transgenic rats in response to angiotensin II: inhibition by nitric oxide. Hypertension. 1993;22:412. Abstract.

42. Kubes P, Suzuki M, Granger DN. Nitric oxide: an endogenous modulator of leucocyte adhesion. Proc Natl Acad Sci U S A. 1991;88:4651–4655.[Abstract/Free Full Text]

43. De Caterina R, Libby P, Peng HB, Thannichal VJ, Rajavashisth TB, Gimbrone MA, Shin WS, Liao JK. Nitric oxide decreases cytokine-induced endothelial activation. J Clin Invest. 1995;96:60–68.

44. Shirahase H, Fujiwara M, Usui H, Kurahashi K. A possible role of thromboxane A2 in endothelium in maintaining resting tone and producing contractile response to acetylcholine and arachidonic acid in canine cerebral arteries. Blood Vessels. 1987;24:117–119.[Medline] [Order article via Infotrieve]

45. Gryglewski RJ, Palmer RMJ, Moncada S. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature. 1986;320:454–456.[Medline] [Order article via Infotrieve]

46. Alexander RW. Hypertension and the pathogenesis of atherosclerosis. Hypertension. 1995;25:155–161.[Abstract/Free Full Text]

47. Clozel M, Kuhn H, Hefti F, Baumgartner HR. Endothelial dysfunction and subendothelial monocyte macrophages in hypertension: effect of angiotensin converting enzyme inhibition. Hypertension. 1991;18:132–141.[Abstract/Free Full Text]

48. Taddei S, Virdis A, Mattei P, Ghiadoni L, Basile Fasolo C, Sudano I, Salvetti A. Hypertension causes premature aging of endothelial function in humans. Hypertension. 1997;29:736–743.[Abstract/Free Full Text]

49. Folsom AR, Wu KK, Shahar E, Davis CE, for the Atherosclerosis Risk in Communities (ARIC) Study Investigators. Association of homeostatic variables with prevalent cardiovascular disease and asymptomatic carotid artery atherosclerosis. Arterioscler Thromb. 1993;13:1829–1836.[Abstract/Free Full Text]

50. Folsom AR, Eckfeldt JH, Weitman S, Ma J, Chambless LE, Barnes RW, Cram KB, Hutchinson RG, for the Atherosclerosis Risk in Communities (ARIC) Study Investigators. Relation of carotid artery wall thickness to diabetes mellitus, fasting glucose and insulin, body size, and physical activity. Stroke. 1994;25:66–73.[Abstract]




This article has been cited by other articles:


Home page
Diabetes CareHome page
D. Versari, E. Daghini, A. Virdis, L. Ghiadoni, and S. Taddei
Endothelial Dysfunction as a Target for Prevention of Cardiovascular Disease
Diabetes Care, November 1, 2009; 32(suppl_2): S314 - S321.
[Full Text] [PDF]


Home page
HeartHome page
S Lavi, J-H Bae, C S Rihal, A Prasad, G W Barsness, R J Lennon, D R Holmes Jr, and A Lerman
Segmental coronary endothelial dysfunction in patients with minimal atherosclerosis is associated with necrotic core plaques
Heart, September 15, 2009; 95(18): 1525 - 1530.
[Abstract] [Full Text] [PDF]


Home page
Exp PhysiolHome page
D. Versari, E. Daghini, A. Virdis, L. Ghiadoni, and S. Taddei
The ageing endothelium, cardiovascular risk and disease in man
Exp Physiol, March 1, 2009; 94(3): 317 - 321.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
A. Cupisti, L. Ghiadoni, C. D'Alessandro, I. Kardasz, E. Morelli, V. Panichi, D. Locati, S. Morandi, A. Saba, G. Barsotti, et al.
Soy protein diet improves endothelial dysfunction in renal transplant patients
Nephrol. Dial. Transplant., January 1, 2007; 22(1): 229 - 234.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. Feletou and P. M. Vanhoutte
Endothelial dysfunction: a multifaceted disorder (The Wiggers Award Lecture)
Am J Physiol Heart Circ Physiol, September 1, 2006; 291(3): H985 - H1002.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Jawa, S. Nachimuthu, M. Pendergrass, S. Asnani, and V. Fonseca
Impaired Vascular Reactivity in African-American Patients with Type 2 Diabetes Mellitus and Microalbuminuria or Proteinuria Despite Angiotensin-Converting Enzyme Inhibitor Therapy
J. Clin. Endocrinol. Metab., January 1, 2006; 91(1): 31 - 35.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
J. W.J. Vriend, A. H. Zwinderman, E. de Groot, J. J.P. Kastelein, B. J. Bouma, and B. J.M. Mulder
Predictive value of mild, residual descending aortic narrowing for blood pressure and vascular damage in patients after repair of aortic coarctation
Eur. Heart J., January 1, 2005; 26(1): 84 - 90.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
U. Paradossi, E. Ciofini, A. Clerico, N. Botto, A. Biagini, and M. G. Colombo
Endothelial Function and Carotid Intima-Media Thickness in Young Healthy Subjects Among Endothelial Nitric Oxide Synthase Glu298->Asp and T-786->C Polymorphisms
Stroke, June 1, 2004; 35(6): 1305 - 1309.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
L. Ghiadoni, A. Magagna, D. Versari, I. Kardasz, Y. Huang, S. Taddei, and A. Salvetti
Different Effect of Antihypertensive Drugs on Conduit Artery Endothelial Function
Hypertension, June 1, 2003; 41(6): 1281 - 1286.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
S. Taddei, A. Virdis, L. Ghiadoni, D. Versari, G. Salvetti, A. Magagna, and A. Salvetti
Calcium Antagonist Treatment by Lercanidipine Prevents Hyperpolarization in Essential Hypertension
Hypertension, April 1, 2003; 41(4): 950 - 955.
[Abstract] [Full Text] [PDF]


Home page
ANGIOLOGYHome page
J. Spacil, R. Ceska, and T. Haas
Flow-Dependent Vasomotor Dysfunction of the Popliteal Artery Related to Common Carotid Artery Intima-Media Thickness
Angiology, October 1, 2001; 52(10): 689 - 695.
[Abstract] [PDF]


Home page
RadiologyHome page
E. B. Spencer, D. H. Sheafor, B. S. Hertzberg, J. D. Bowie, R. C. Nelson, B. A. Carroll, and M. A. Kliewer
Nonstenotic Internal Carotid Arteries: Effects of Age and Blood Pressure at the Time of Scanning on Doppler US Velocity Measurements
Radiology, July 1, 2001; 220(1): 174 - 178.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. Rubenfire, S. Rajagopalan, and L. Mosca
Carotid artery vasoreactivity in response to sympathetic stress correlates with coronary disease risk and is independent of wall thickness
J. Am. Coll. Cardiol., December 1, 2000; 36(7): 2192 - 2197.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J. O. Toikka, H. Laine, M. Ahotupa, A. Haapanen, J. S. A. Viikari, J. J. Hartiala, and O. T Raitakari
Increased Arterial Intima-Media Thickness and In Vivo LDL Oxidation in Young Men With Borderline Hypertension
Hypertension, December 1, 2000; 36(6): 929 - 933.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
G. Gaeta, M. De Michele, S. Cuomo, P. Guarini, M. C. Foglia, M. G. Bond, and M. Trevisan
Arterial Abnormalities in the Offspring of Patients with Premature Myocardial Infarction
N. Engl. J. Med., September 21, 2000; 343(12): 840 - 846.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. Virdis, L. Ghiadoni, S. Pinto, M. Lombardo, F. Petraglia, A. Gennazzani, S. Buralli, S. Taddei, and A. Salvetti
Mechanisms Responsible for Endothelial Dysfunction Associated With Acute Estrogen Deprivation in Normotensive Women
Circulation, May 16, 2000; 101(19): 2258 - 2263.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
S. P. Didion, C. D. Sigmund, F. M. Faraci, and Z. S. Katusic
Impaired Endothelial Function in Transgenic Mice Expressing Both Human Renin and Human Angiotensinogen • Editorial Comment
Stroke, March 1, 2000; 31(3): 760 - 765.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ghiadoni, L.
Right arrow Articles by Salvetti, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ghiadoni, L.
Right arrow Articles by Salvetti, A.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*High Blood Pressure